Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Surveillance of the tumor mutanome by T cells during progression from primary to recurrent ovarian cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Mar 2014

Wick Darin A, Webb John R, Nielsen Julie S, Martin Spencer D, Kroeger David R, Milne Katy, Castellarin Mauro, Twumasi-Boateng Kwame, Watson Peter H, Holt Rob A, Nelson Brad H

Abstract excerpt

PURPOSE: Cancers accumulate mutations over time, each of which brings the potential for recognition by the immune system. We evaluated T-cell recognition of the tumor mutanome in patients with ovarian cancer undergoing standard treatment. EXPERIMENTAL DESIGN: Tumor-associated T cells from 3 patie...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CD8-Positive T-Lymphocytes
Share to Epitopes, T-Lymphocyte

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HLA Antigens

Share to Hydroxysteroid Dehydrogenases

Share to Immunologic Surveillance

Share to Lymphocytes, Tumor-Infiltrating

Share to Neoplasm Grading

Share to Recurrence

Source

Identifiers

PMID: 24323902
DOI: 10.1158/1078-0432.CCR-13-2147

Genes

HSDL1

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24323902-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Surveillance of the tumor mutanome by T cells during progression from primary to recurrent ovarian cancer.PMID 24323902Read ↗

Variable Mutation Expression in Human Cancers: A "Hide-and-Seek" Mechanism Linked to Differential MHC-I Presentation Dynamics.Semantic proximity Read ↗

Low Mutation Burden in Ovarian Cancer May Limit the Utility of Neoantigen-Targeted Vaccines.Semantic proximity Read ↗

The mutational load and a T-cell inflamed tumor phenotype identify ovarian cancer patients rendering tumor-reactive T cells from PD-1+ tumor-infiltrating lymphocytesSemantic proximity Read ↗

Persistent mutation burden drives sustained anti-tumor immune responses.Semantic proximity Read ↗

Unique immune characteristics and differential anti-PD-1-mediated reinvigoration potential of CD8+ TILs based on BRCA1/2 mutation status in epithelial ovarian cancers.Semantic proximity Read ↗

Unique genomic and neoepitope landscapes across tumors: a study across time, tissues, and space within a single lynch syndrome patient.Semantic proximity Read ↗

Germline-mediated immunoediting sculpts breast cancer subtypes and metastatic proclivitySemantic proximity Read ↗

T-cell Responses to TP53 "Hotspot" Mutations and Unique Neoantigens Expressed by Human Ovarian Cancers.Semantic proximity Read ↗

Myeloid cell networks determine reinstatement of original immune environments in recurrent ovarian cancerSemantic proximity Read ↗

Germline-mediated immunoediting sculpts breast cancer subtypes and metastatic proclivitySemantic proximity Read ↗

The mutational load and a T-cell inflamed tumour phenotype identify ovarian cancer patients rendering tumour-reactive T cells from PD-1+ tumour-infiltrating lymphocytes.Semantic proximity Read ↗

Neoantigens in Ovarian Cancer: Embarrassment of Riches or Needles in a Haystack?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.